MAPT and Alzheimer disease: Transgenic rats, such as the TgF344‐AD strain, represent a more accurate model of AD pathogenesis, and exhibit elevated levels of toxic Aβ peptides (Aβ 1‐40, Aβ 1‐42) and tauopathy without a mutated tau gene, hence better mimicking human AD pathology than mice.30